Viewing Study NCT06636435

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2026-02-06 @ 12:57 AM
Study NCT ID: NCT06636435
Status: RECRUITING
Last Update Posted: 2025-09-19
First Post: 2024-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Sponsor: Chiome Bioscience Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Hepatocellular Carcinoma (HCC) View
None Malignant Melanoma View
None Pediatric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DLK1 View
None First in human View
None Phase I View
None Antibody View
None solid tumor View
None Hepatocellular Carcinoma View
None CBA-1205 View
None Melanoma View
None Pediatric Cancer View